We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Phillip Pierorazio

Phillip M. Pierorazio MD

Assistant Professor of Urology and Oncology, James Buchanan Brady Urological Institute, Department of Urology and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Dr. Phillip M. Pierorazio, joined the staff of the James Buchanan Brady Urological Institute, Department of Urology and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Assistant Professor of Urology and Oncology.  Prior to starting residency, he was accepted and spent a year as a Doris Duke Clinical Research Fellow in Urologic Oncology. Dr. Pierorazio has expertise in all malignancies of the urinary tract, performs both open and minimally-invasive surgeries including laparoscopic and robotic surgeries of the kidney, bladder and prostate, but has a special interest in kidney cancer, including partial nephrectomy for early stage disease and high-risk surgeries for patients with advanced urological cancers.  Paralleling his clinical interests, runs the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry – one of the largest studies of its kind – following patients with small, localized kidney tumors (cT1a, ≤4cm) who choose active surveillance or immediate surgery. The National Comprehensive Cancer Network (NCCN) recently awarded Dr. Pierorazio a Young Investigator’s Award for his work with the DISSRM Registry.  In addition, Dr. Pierorazio is the Director of Testicular Cancer and Director of Social Media at the Brady Urological Institute.  Dr. Pierorazio is the recipient of a number of academic awards including the American Urologic Association Essay Contest and has presented his research at a number of national and international meetings. He has written and published numerous research articles, textbook chapters, and video presentations in the field Urologic Oncology.